Skip to main content

Advertisement

Table 1 Distribution of T-lymphocyte subsets (mean ± SE) in DLBCL patients at baseline and after three cycles of chemotherapy

From: Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy

Group N CD3+T cells (%) CD3+CD4+T cells (%) CD3+CD8+T cells (%) Ratio of CD4+/CD8+ CD4+/CD25+T cells (%)
DLBCL patients at baseline 56 72.09 ± 3.16 32.31 ± 3.65 37.53 ± 6.46 0.85 ± 0.49 5.48 ± 4.96
DLBCL after three cycles of chemotherapy 56 71.24 ± 6.2 34.09 ± 4.63 32.51 ± 5.25 1.06 ± 0.87 8.32 ± 3.54
Healthy controls 26 72.90 ± 5.83 41.78 ± 4.23 28.51 ± 2.14 1.47 ± 0.27 3.68 ± 1.03